NS

Nikolay Sinakevich

Active Director Director DIN 02388029
DIN 02388029 First appointment Dec 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2008
Shareholding value •••• Premium profile

About Nikolay Sinakevich

Data last updated:

Nikolay Sinakevich is a Director at Psi Cro Pharma India Private Limited (since 2008). The company operates in Pharma. Psi Cro Pharma India Private Limited reported revenue of ₹4.62 Cr (FY 2021).

DIN 02388029
Primary Designation Director
Industry Pharma
First Appointment 23 Dec 2008
Oldest Company Age 18 yrs
Largest company Psi Cro Pharma India Private Limited · ₹4.62 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Psi Cro Pharma India Private Limited U74999KA2008FTC047698
Director23 Dec 20082008₹4.62 Cr (FY 2021)Active

Board colleagues of Nikolay Sinakevich

Directorship timeline

Open interactive timeline →
Psi Cro Pharma India Private Limited
Premium access

Shareholding and investment profile for Nikolay Sinakevich

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikolay Sinakevich

Nikolay Sinakevich currently holds 1 directorship: Psi Cro Pharma India Private Limited (Director, since 23 Dec 2008, revenue ₹4.62 Cr (FY 2021)).

Nikolay Sinakevich was first appointed on 23 Dec 2008 as Director at Psi Cro Pharma India Private Limited.

The current boards of Nikolay Sinakevich's companies include Albertine Varone (Psi Cro Pharma India Private Limited), Andrey Kozhemyakin (Psi Cro Pharma India Private Limited), Srikanth Narasimhan (Psi Cro Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available